Signal pathways and precision therapy of small-cell lung cancer

Small-cell lung cancer (SCLC) encounters up 15% of all lung cancers, and is characterized by a high rate of proliferation, a tendency for early metastasis and generally poor prognosis. Most of the patients present with distant metastatic disease at the time of clinical diagnosis, and only one-third...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Min, Zhao, Yu, Arkenau, Hendrik-Tobias, Lao, Tongnei, Chu, Li, Xu, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200817/
https://www.ncbi.nlm.nih.gov/pubmed/35705538
http://dx.doi.org/10.1038/s41392-022-01013-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200817/
https://www.ncbi.nlm.nih.gov/pubmed/35705538
http://dx.doi.org/10.1038/s41392-022-01013-y

Ejemplares similares